NCT02757144View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Healthy
Interventions
DRUG

DWP14012

DWP14012 tablets

DRUG

Placebo

DWP14012 placebo-matching tablets, Active control placebo-matching tablets

DRUG

Esomeprazole

Nexium®

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY